Rational Pharmacotherapy in Cardiology

Advanced search

Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias

Full Text:


Aim. To study the late results of medical and interventional treatment in patients with morphologically verified nature of idiopathic arrhythmias.

Methods. The prospective study included 20 patients (mean age 43.1±11.3 years, 10 female) with atrial fibrillation (AF), supraventricular and ventricular extrasystole, supraventricular and ventricular tachycardia, conduction disturbance without structural heart changes. In addition to the standard examination, the level of anti-heart antibodies was initially determined; endomyocardial biopsy (EMB) of the right ventricle with PCR study for the viral genome; DNA diagnostics (n=4), coronary angioraphy (n=6), skin biopsy (n=1) were performed. The median follow-up was 134 [128; 138] months.

Results. By EMB in the initial examination were diagnosed: active (n=8)/borderline (n=3) infectious immune myocarditis; parvovirus-positive endomyocarditis (n=1); undifferentiated vasculitis (n=2); myocardial vasculitis (n=1); Fabry disease (n=1); arrhythmogenic right ventricular dysplasia (n=1); unspecified cardiomyopathy (n=2). Anti-heart antibodies were the most important in myocarditis diagnosis and monitoring. All patients with myocarditis/vasculitis (n=15) received its basic therapy: acyclovir (n=10); immunoglobulin G 10-12.5 g (n=2); hydroxychloroquine 200 mg/day (n=15); glucocorticoids (n=14); azathioprine 150 mg/day (n=2). The late results were evaluated in all patients with myocarditis. Initially, in 62.5% of patients a resistance of AF to all antiarrhythmic drugs was noted. After treatment the average frequency of AF paroxysms decreased (from 8 [5; 8] to 3 [1,25; 7,75] points). By the end of the follow-up, six patients underwent radiofrequency ablation (RFA) for AF, the full effect was achieved once. All patients without RFA have AF partially or completely resistant to drugs. Two patients (without RFA) died from ischemic stroke/ pulmonary embolism.

Conclusion. Using EMB the causes of idiopathic arrhythmias (mainly AF) were diagnosed: immune inflammatory diseases in 75% and genetic in 25% of patients. As a result of complex treatment, the general burden of arrhythmias has decreased. But the presence of myocarditis and primary cardiomyopathy, without reducing the cardiac contractility and dilatation, does not allow achieving a stable antiarrhythmic effect. Lethality for 11 years was 10%. The causes of death were thromboembolic complications.

About the Authors

O. V. Blagova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Olga V. Blagova

A. V. Nedostup
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Alexander V. Nedostup

E. A. Kogan
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Evgeniya A. Kogan


1. Kirchhof P, Benussi S, Kotecha D, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. DOI:10.1093/eurheartj/ehw210.

2. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-867. DOI:10.1093/eurheartj/ehv316.

3. Gorenek B, Fisher JD, Kudaiberdieva G, et al. Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice: A state-of-the-art review by the American College of Cardiology Electrophysiology Council. J Interv Card Electrophysiol. 2020;57(1):5-26. DOI:10.1007/s10840-019-00655-3.

4. Caforio AL, Pankuweit S, Arbustini E, et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48. DOI:10.1093/eurheartj/eht210.

5. Blagova OV, Nedostup AV, Kogan EA, et al. «Idiopathic» arrhythmias as a symptom of latent cardiac disease: nosologic diagnostics using endomyocardial biopsy. Kardiologiyai Serdechno-Sosudistaya Hirurgiya. 2010;3(1):56-63 (In Russ.)

6. Blagova OV, Nedostup AV, Kogan EA, et al. [Possibilities myocardial biopsy in the diagnosis of myocarditis verification in patients with idiopathic arrhythmias]. Kardiologiia. 2013;53(11):21-30 (In Russ.)

7. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation.1997;96(4):1180-4. DOI:10.1161/01.cir.96.4.1180.

8. Batalov RE, Rogovskaya YV, Ryabov VV, et al. Idiopathic form of atrial fibrillation, inflammation and clinical results of radiofrequency ablation. Russian Journal of Cardiology. 2014;(12):7-12 (In Russ.) DOI:10.15829/1560-4071-2014-12-7-12.

9. Grohotova VV, Tatarskij RB, Lebedev DS, et al. Catheter ablation of non-coronarogenic ventricular tachyarrhythmias: an early and long-term effectiveness of the procedure depending on the etiology of rhythm disturbances. Serdce. 2014;13(1):3-10 (In Russ.)

10. Nedostup AV, Blagova OV, Kogan EA, et al. Myocardial vasculitis: nosological affiliation, clinical presentation, diagnosis, treatment. Kardiologiyaiserdechno-sosudnstayahirurgiya, 2011; 4(3): 85-92 (In Russ.)

11. Safiullina AA, Uskach TM, Zhirov IV, et al. Atrial myocarditis in a patient with Takayasu arteritis. Ter Arkhiv. 2019;91(6):103-9 (In Russ.) DOI:10.26442/00403660.2019.06.000047.

12. Blagova OV, Nedostup AV, Kogan EA. Chapter 3. Syndrome of rhythm and heart conductivity disorders ("idiopathic" arrhythmias). V. В: Blagova OV, Nedostup AV, Kogan EA. Myocardial and pericardial diseases: from syndromes to diagnosis and treatment. Moscow: GEOTAR-Media; 2019. p. 83-202 (In Russ.)

13. Killu AM, Mehta N, Zheng Q, et al. Endomyocardial biopsy at the time of ablation or device implantation. J Interv Card Electrophysiol. 2018;52(2):163-9. DOI:10.1007/s10840-018-0358-7.

14. Pavlicek V, Kindermann I, Wintrich J, et al. Ventricular arrhythmias and myocardial inflammation: Long-term follow-up of patients with suspected myocarditis. Int J Cardiol. 2019;274:132-7. DOI:10.1016/j.ijcard.2018.07.142.

15. Vasichkina E, Poghosyan H, Mitrofanova L, et al. Right ventricular endomyocardial biopsy in children and adolescents with drug-refractory arrhythmia. Cardiol Young. 2017;27(3):435-42. DOI:10.1017/S1047951116000688.

16. Vassalini M, Verzeletti A, Restori M, De Ferrari F. An autopsy study of sudden cardiac death in persons aged 1-40 years in Brescia (Italy). J Cardiovasc Med (Hagerstown). 2016;17(6):446-53. DOI:10.2459/JCM.0000000000000234.

17. Frustaci A, Caldarulo M, Buffon A, et al. Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest. 1991;100(2):303-6. DOI:10.1378/chest.100.2.303.

18. Frustaci A, Verardo R, Grande C, et al. Arrhythmic Phenotype of Myocarditis Sustained by a Prominent Infiltration of Conduction Tissue. Circ Cardiovasc Imaging. 2019;12(8):e009448. DOI:10.1161/CIRCIMAGING.119.009448.

19. Andreini D, Dello Russo A, Pontone G, et al. CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography. JACC Cardiovasc Imaging. 2020;13(2 Pt 1):410-21. DOI:10.1016/j.jcmg.2019.04.023.

20. Lakkireddy D, Turagam MK, Yarlagadda B, et al. Myocarditis Causing Premature Ventricular Contractions: Insights From the MAVERIC Registry. Circ Arrhythm Electrophysiol. 2019;12(12):e007520. DOI:10.1161/CIRCEP.119.007520.

21. Goette A, Kalman JM, Aguinaga L, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Heart Rhythm. 2017;14(1):e3-e40. DOI:10.1016/j.hrthm.2016.05.028.


For citations:

Blagova O.V., Nedostup A.V., Kogan E.A. Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias. Rational Pharmacotherapy in Cardiology. 2021;17(5):729-737. (In Russ.)

Views: 301

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)